PharmaMénta Aps: Financial statements 2015
CVR: 25615697
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
PharmaMénta Aps (CVR 25615697) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 126,362 and a net result of DKK 204,229 compared with DKK 125,362 the year before. Equity in the 2015 report amounted to DKK 4,463,421. The solvency ratio was 98.4%.
- Gross Profit
- DKK 126,362
- Profit/Loss
- DKK 204,229
- Equity
- DKK 4,463,421
- Total Assets
- DKK 4,535,693
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 126 t. | 204 t. | 4.5 mio. | - |
| 2014 | - | -2 t. | 125 t. | 4.3 mio. | - |
| 2013 | - | -7 t. | 136 t. | 4.1 mio. | - |
| 2012 | - | -6 t. | 286 t. | 4 mio. | - |
Official annual report
How creditworthy is PharmaMénta Aps?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
PharmaMénta Aps has published its annual report for 2014. Gross profit came to DKK -2,025, and the net result was DKK 125,362.
About PharmaMénta Aps
PharmaMénta Aps is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2000. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jimmi Javed Christensen Malik. The board consists of Lasse Hvingelby Kikkenborg (chair), Jimmi Javed Christensen Malik and Torben Hvingelby Pedersen. The company is owned by Torben Hvingelby Pedersen, LHK Holding Esbjerg ApS and JMINT Holding ApS. The company has 3 employees (2008). In 2025, the company reported a gross profit of DKK 5,249,012 and a net result of DKK 2,364,968 compared with DKK 2,121,363 the year before. Equity in the 2025 report amounted to DKK 5,130,022.